Related by context. Frequent words. (Click for all words.) 81 Patients Undergoing 81 Cardiovascular Events 79 Elderly Patients 79 Postmenopausal Women 79 Patients Treated 78 Well Tolerated 78 Diabetic Patients 78 Heart Failure Patients 77 Enoxaparin 77 Lung Cancer Patients 77 Low Dose 77 Prostate Cancer Patients 77 Monotherapy 77 Advanced Prostate Cancer 77 Combination Therapy 76 Clinical Trial Results 76 Regimens 75 Phase III Clinical Trial 75 Venous Thromboembolism 75 Hormone Therapy 75 Blood Clots 75 Blood Thinner 74 Increases Risk 74 Generic Version 74 Reduces Risk 74 Drug Candidate 74 Chronic Hepatitis C 74 Percutaneous Coronary Intervention 74 Metastatic Colorectal Cancer 74 Overactive Bladder 74 Breast Cancer Patients 74 Gastric Cancer 74 Capecitabine 73 Cholesterol Drug 73 Meta Analysis 73 Prostate Cancer Treatment 73 Cancer Treatments 73 Benign Prostatic Hyperplasia 73 Study Demonstrates 73 Phase III Trial 73 Blood Vessels 73 Preclinical Data 72 Patient Enrollment 72 Pivotal Trial 72 Allergic Rhinitis 72 Gum Disease 72 Blood Flow 72 Significantly Reduces 72 II Clinical Trial 72 Stenting 72 Drug Resistant 72 Induces 72 Metastatic Melanoma 72 Antipsychotic 72 Tolerability 72 Breast Cancer Treatment 72 Randomized Controlled Trial 72 Survival Rates 72 Bypass Surgery 72 Increased Risk 72 Pivotal Phase 72 Urinary Incontinence 71 Drug Eluting Stents 71 Pioglitazone 71 Completes Enrollment 71 Cognitive Decline 71 Recombinant Human 71 Pulmonary Arterial Hypertension 71 Acute Coronary Syndromes 71 Bevacizumab 71 Extended Release 71 Pivotal Phase III 71 Antihypertensive 71 Cancer Cells 71 J Am Coll 70 Dialysis Patients 70 C Reactive Protein 70 Radiation Exposure 70 Insulin Resistance 70 Inhibits 70 Acute Myocardial Infarction 70 Lenalidomide 70 FDA Clears 70 Patient Outcomes 70 Tacrolimus 70 Birth Weight 70 Breast Cancer Risk 70 Vertebroplasty 70 Newly Diagnosed 70 Aliskiren 69 Kidney Stones 69 Subcutaneous 69 Prophylaxis 69 Gemcitabine 69 Shows Promise 69 Anti TNF 69 FDA Accepts 69 Drug Eluting Stent 68 Systematic Review 68 Reduce Risk 68 Ischemic